| GWEZX | VSMAX | GWEZX / VSMAX | |
| Total Expense Ratio | 0.90 | 0.05 | 1,800% |
| Annual Report Gross Expense Ratio | 0.90 | 0.05 | 1,800% |
| Fund Existence | 9 years | 25 years | - |
| Gain YTD | 5.060 | 5.535 | 91% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 3000 | 166,667% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 727M | 162B | 0% |
| Annual Yield % from dividends | 0.22 | 1.27 | 17% |
| Returns for 1 year | 1.30 | 10.71 | 12% |
| Returns for 3 years | 11.31 | 33.11 | 34% |
| Returns for 5 years | 5.70 | 31.93 | 18% |
| Returns for 10 years | N/A | 186.87 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IWS | 148.46 | 0.52 | +0.35% |
| iShares Russell Mid-Cap Value ETF | |||
| JHEM | 35.36 | 0.12 | +0.34% |
| JHancock Multifactor Em Mkts ETF | |||
| IG | 20.84 | 0.01 | +0.05% |
| Principal Investment Grd Corp Actv ETF | |||
| SEIS | 29.49 | -0.13 | -0.44% |
| SEI Select Small Cap ETF | |||
| FTXH | 34.20 | -0.18 | -0.53% |
| First Trust Nasdaq Pharmaceuticals ETF | |||